enavogliflozin Tablets 0.3 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
South Korea
Manufacturer #7042
A pharmaceutical manufacturer engaged in the research, development, production and global supply of a broad range of pharmaceutical products, including prescription drugs, over-the-counter medicines and biologic therapies in finished dosage forms such as tablets, capsules, ointments, injections and liquids, as well as active pharmaceutical ingredients. The company combines integrated R&D with GMP-compliant manufacturing capabilities and commercial operations to support quality, safety and reliability in its pharmaceutical products for diverse therapeutic needs.